RecruitingNot applicableNCT06796504
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
Sponsor: SetPoint Medical Corporation
Irvine, CA · +8 more sites
Multiple Sclerosis clinical trials in Irvine, CA
2 recruiting multiple sclerosis studies with a site in Irvine, CA.
RecruitingPhase 3NCT06846281
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Sponsor: Novartis Pharmaceuticals
Irvine, CA · +43 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.